Cambridge Trust Co. decreased its holdings in shares of Cigna Corp (NYSE:CI) by 12.9% during the 1st quarter, Holdings Channel reports. The firm owned 1,497 shares of the health services provider’s stock after selling 222 shares during the period. Cambridge Trust Co.’s holdings in Cigna were worth $241,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in CI. Oregon Public Employees Retirement Fund grew its stake in Cigna by 42,687.1% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 31,752,725 shares of the health services provider’s stock valued at $167,000 after buying an additional 31,678,514 shares during the last quarter. BlackRock Inc. grew its stake in Cigna by 59.4% in the 4th quarter. BlackRock Inc. now owns 26,892,201 shares of the health services provider’s stock valued at $5,107,369,000 after buying an additional 10,021,719 shares during the last quarter. Norges Bank bought a new stake in Cigna in the 4th quarter valued at $737,238,000. Macquarie Group Ltd. boosted its holdings in Cigna by 1,413.5% in the 4th quarter. Macquarie Group Ltd. now owns 3,711,240 shares of the health services provider’s stock valued at $704,890,000 after purchasing an additional 3,466,030 shares during the period. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in Cigna by 179.2% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 4,456,861 shares of the health services provider’s stock valued at $846,447,000 after purchasing an additional 2,860,291 shares during the period. Institutional investors own 88.31% of the company’s stock.
A number of analysts have weighed in on CI shares. ValuEngine downgraded shares of Cigna from a “hold” rating to a “sell” rating in a report on Friday, December 28th. Edward Jones started coverage on shares of Cigna in a report on Wednesday, January 2nd. They issued a “buy” rating for the company. Raymond James raised shares of Cigna from a “market perform” rating to an “outperform” rating and set a $187.17 price target for the company in a report on Thursday, January 3rd. Zacks Investment Research downgraded shares of Cigna from a “buy” rating to a “hold” rating in a report on Thursday, January 3rd. Finally, Wells Fargo & Co reduced their price target on shares of Cigna from $221.00 to $200.00 and set a “market perform” rating for the company in a report on Thursday, January 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Cigna has a consensus rating of “Buy” and a consensus price target of $225.62.
NYSE:CI opened at $153.82 on Wednesday. The stock has a market cap of $56.63 billion, a PE ratio of 10.82, a price-to-earnings-growth ratio of 0.73 and a beta of 0.71. Cigna Corp has a 52 week low of $141.95 and a 52 week high of $226.60. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.96.
Cigna (NYSE:CI) last released its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 EPS for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). The business had revenue of $13.75 billion for the quarter, compared to the consensus estimate of $11.38 billion. Cigna had a return on equity of 16.64% and a net margin of 5.42%. Cigna’s revenue was up 29.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.94 earnings per share. On average, equities research analysts expect that Cigna Corp will post 16.43 EPS for the current year.
The firm also recently disclosed a special dividend, which was paid on Wednesday, April 10th. Stockholders of record on Monday, March 11th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, March 8th. Cigna’s payout ratio is 0.28%.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/24/cambridge-trust-co-has-241000-stake-in-cigna-corp-ci.html.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Article: Cost of equity and a company’s balance sheet
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.